NCT06781333View on ClinicalTrials.gov

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

PHASE2RecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

June 15, 2026

Study Completion Date

June 15, 2026

Conditions
Alzheimer DiseaseAgitation in Dementia
Interventions
BIOLOGICAL

hMSC

Participants will come in person to receive one intravenous infusion of approximately 25 million cells up to 20 minutes.

Trial Locations (1)

33136

RECRUITING

University of Miami Department of Neurology, Miami

All Listed Sponsors
lead

Bernard (Barry) Baumel

OTHER